Cargando…
Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297624/ https://www.ncbi.nlm.nih.gov/pubmed/16277704 http://dx.doi.org/10.1186/cc3798 |